Penile cancer
A Thomas, A Necchi, A Muneer… - Nature Reviews …, 2021 - nature.com
Penile squamous cell carcinoma (PSCC) is a rare cancer with orphan disease designation
and a prevalence of 0.1–1 per 100,000 men in high-income countries, but it constitutes up to …
and a prevalence of 0.1–1 per 100,000 men in high-income countries, but it constitutes up to …
Management of advanced penile cancer
Penile squamous cell carcinoma (PSCC) is a rare cancer, with approximately 2000 new
cases in the United States and 35,000 globally every year. Multiple risk factors are involved …
cases in the United States and 35,000 globally every year. Multiple risk factors are involved …
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Background Treatment options for penile squamous cell carcinoma are limited. We sought to
investigate clinical outcomes and safety profiles of patients with penile squamous cell …
investigate clinical outcomes and safety profiles of patients with penile squamous cell …
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma
Objectives There is an unmet need for therapeutically relevant biomarkers for advanced
penile squamous cell carcinoma (pSCC). Proposed immunohistochemistry (IHC)-based …
penile squamous cell carcinoma (pSCC). Proposed immunohistochemistry (IHC)-based …
Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial
Background: Treatment options for unresectable, locally advanced or metastatic penile
squamous cell carcinoma (SCC) are limited. Previous studies have shown that 40–62% of …
squamous cell carcinoma (SCC) are limited. Previous studies have shown that 40–62% of …
Case report: two cases of chemotherapy refractory metastatic penile squamous cell carcinoma with extreme durable response to pembrolizumab
J Chahoud, WP Skelton IV, PE Spiess, C Walko… - Frontiers in …, 2020 - frontiersin.org
Background Penile squamous cell carcinoma (PSCC) is a rare malignancy, and those
patients with metastatic disease have limited treatment options. Treatment is largely …
patients with metastatic disease have limited treatment options. Treatment is largely …
A global approach to improving penile cancer care
Rare tumours such as penile carcinoma have been largely neglected by the urology
scientific community in favour of more common—and, therefore, more easily fundable …
scientific community in favour of more common—and, therefore, more easily fundable …
Recent advances in the management of penile cancer: a contemporary review of the literature
CE Stecca, M Alt, DM Jiang, P Chung, JM Crook… - Oncology and …, 2021 - Springer
Penile cancer is a rare condition, which mostly affects men in their sixth decade of life. The
most common histology is squamous cell carcinoma (SCC), with about half of the cases …
most common histology is squamous cell carcinoma (SCC), with about half of the cases …
[HTML][HTML] Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer …
L Liu, Y Liu, Y **a, G Wang, X Zhang, H Zhang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Cancer stem cells (CSCs) are characterized by self-renewal and unlimited proliferation,
providing a basis for tumor occurrence, metastasis, and recurrence. Because CSCs are …
providing a basis for tumor occurrence, metastasis, and recurrence. Because CSCs are …
Current management and future perspectives of penile cancer: An updated review
F Peyraud, C Allenet, M Gross-Goupil… - Cancer Treatment …, 2020 - Elsevier
Penile cancer (PeCa) is a rare disease worldwide, accounting for less than one percent of
all malignancies in men. It usually presents as a painless ulcer or lump on the head of the …
all malignancies in men. It usually presents as a painless ulcer or lump on the head of the …